KYMR同业对比
KYMR 与SPDR S&P Biotech ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:XBI 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KYMR本股 | — | — | — | — | — | — | — | — | — | — | — | — |
| MDGL | $11.1B#5 | — | 21.2x#9 | 11.6x#4 | 432.1%#2 | 38.1%#4 | -31.3%#5 | -55.0%#7 | -52.5%#3 | — | 59.3%#9 | — |
| TGTX | $7.1B#11 | 16.2x#1 | 12.1x#4 | 11.5x#3 | 87.3%#6 | 1811.1%#1 | 20.0%#3 | 76.7%#1 | 13.9%#1 | — | 31.8%#10 | — |
| INSM | $21.3B#2 | — | 30.3x#10 | 35.2x#7 | 66.7%#7 | -39.7%#8 | -205.6%#7 | -181.1%#10 | -185.1%#5 | 4#1 | -9.5%#13 | — |
| SRRK | $5.5B#14 | — | 19.9x#8 | — | — | -53.7%#10 | — | -137.0%#8 | -901.6%#6 | — | 26.0%#12 | — |
| APGE | $10.0B#7 | — | — | — | — | -40.5%#9 | — | — | — | — | 254.9%#3 | — |
| PTGX | $8.5B#9 | — | 13.0x#5 | 184.8x#9 | -89.4%#10 | -147.3%#12 | -343.6%#8 | -19.9%#4 | -33.5%#2 | — | 145.7%#5 | — |
| SMMT | $10.4B#6 | — | 16.5x#6 | — | — | -387.8%#13 | — | -171.4%#9 | — | — | -51.8%#14 | — |
| UTHR | $21.9B#1 | 19.1x#2 | 3.7x#1 | 6.9x#2 | 10.6%#8 | 11.7%#5 | 46.9%#2 | 22.6%#2 | — | — | 75.3%#7 | — |
| PRAX | $8.5B#10 | — | 6.0x#2 | — | -100.0%#11 | -65.6%#11 | — | -21.5%#5 | — | — | 464.4%#1 | — |
| ARWR | $12.1B#4 | — | 19.7x#7 | 14.6x#5 | 23258.2%#1 | 99.7%#3 | 11.9%#4 | -0.3%#3 | — | — | 440.1%#2 | — |
| COGT | $6.6B#12 | — | 10.9x#3 | 843.3x#10 | -65.0%#9 | -28.6%#6 | -4235.3%#10 | -54.1%#6 | -81.2%#4 | — | 240.7%#4 | — |
| BBIO | $15.7B#3 | — | — | 31.2x#6 | 126.3%#4 | — | -104.2%#6 | — | — | — | 68.7%#8 | 0.0%#1 |
| PTCT | $5.7B#13 | — | — | 3.3x#1 | 114.5%#5 | 288.0%#2 | 50.1%#1 | — | — | — | 30.8%#11 | — |
| CYTK | $9.5B#8 | — | — | 108.1x#8 | 376.6%#3 | -33.2%#7 | -695.4%#9 | — | — | — | 108.5%#6 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议